Status:
COMPLETED
Intensity Modulated Radiotherapy With Concomitant Boost in Breast Cancer
Lead Sponsor:
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions:
Breast Cancer
Radiation Toxicity
Eligibility:
FEMALE
Brief Summary
To assess feasibility of postoperative IMRT with concomitant boost in moderate-high risk breast cancer in terms of late toxicity and local control
Detailed Description
Patients treated conservatively with moderate-high risk breast cancer were treated with IMRT plus concomitant boost to surgical bed (up to a dose of 50 Gy to whole breast and 60 Gy to the tumor bed). ...
Eligibility Criteria
Inclusion
- histologically confirmed invasive breast cancer (pT1-4) with at least one of these characteristics: 3 or more metastatic axillary nodes, pre or peri-menopausal status, close resection margins
- breast conservative surgery
Exclusion
- positive margins
- distant metastases
Key Trial Info
Start Date :
June 1 2001
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2017
Estimated Enrollment :
451 Patients enrolled
Trial Details
Trial ID
NCT03471741
Start Date
June 1 2001
End Date
December 31 2017
Last Update
March 21 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.